HomeNATHBIOGEN • NSE
add
Nath Bio-Genes (I) Ltd
Previous close
₹158.92
Day range
₹158.88 - ₹163.13
Year range
₹137.55 - ₹238.69
Market cap
3.05B INR
Avg Volume
18.02K
P/E ratio
7.00
Dividend yield
1.24%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 438.50M | 36.21% |
Operating expense | 216.28M | 37.42% |
Net income | 27.53M | 147.31% |
Net profit margin | 6.28 | 81.50% |
Earnings per share | — | — |
EBITDA | 60.98M | 26.69% |
Effective tax rate | 11.75% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.42M | -64.25% |
Total assets | 10.14B | 22.41% |
Total liabilities | 3.34B | 77.63% |
Total equity | 6.80B | — |
Shares outstanding | 19.67M | — |
Price to book | 0.46 | — |
Return on assets | — | — |
Return on capital | 1.60% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 27.53M | 147.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1979
Website
Employees
451
